Related Experiment Video
Updated: May 24, 2025

08:32
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
10.2K
Balb/c mice are protected from glucose and acute cold intolerance
Marcela R Simoes1, Bruna Bombassaro1, Ana Luisa Gallo-Ferraz1
1Obesity and Comorbidities Research Center, University of Campinas (UNICAMP), Campinas, São Paulo 13083-864, Brazil.
Summary
Balb/c mice show enhanced cold and glucose tolerance due to increased brown adipose tissue oxygen consumption. This protection is linked to the PM20D1 regulator, independent of diet and uncoupling protein 1.
Area of Science:
- Metabolic disorders
- Thermogenesis regulation
- Adipose tissue function
Background:
- Brown adipose tissue (BAT) is a key target for metabolic disorder treatments.
- Genetic and environmental factors influence BAT function and thermogenesis.
- Investigating gene-environment interactions can reveal novel regulatory mechanisms.
Purpose of the Study:
- To compare the BAT function and metabolic response of three distinct mouse strains under cold exposure and high-fat diet.
- To identify mechanisms underlying superior cold and glucose tolerance in specific mouse strains.
- To explore the role of PM20D1 in thermogenesis and metabolic regulation.
Main Methods:
- Comparative analysis of Balb/c, C57BL/6, and Swiss mice strains.
- Assessment of brown adipose tissue (BAT) function, including oxygen consumption and uncoupling protein 1 (UCP1) expression.
- Gene expression analysis of PM20D1 in BAT.
- In vivo immunoneutralization of PM20D1 and in silico knockout studies.
Main Results:
- Balb/c mice exhibited superior glucose tolerance and cold tolerance compared to other strains.
- Higher BAT oxygen consumption in Balb/c mice, independent of UCP1.
- Elevated PM20D1 gene expression in Balb/c mouse BAT.
- PM20D1 inhibition worsened glucose levels and cold tolerance in Balb/c mice.
Conclusions:
- Balb/c mice possess inherent protection against glucose intolerance and cold stress, irrespective of diet.
- PM20D1 plays a significant role in this protection through an uncoupling protein 1-independent pathway.
- PM20D1 emerges as a potential therapeutic target for metabolic disorders.

